Yueqin Chen
305 Eastern Zhongshan Rd
Nanjing, 210002, China
Nanjing, 210002, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Differential type 2 diabetes risk and weight-loss associations across MASLD genetic susceptibility patterns.
Journal: Nutrition, metabolism, and cardiovascular diseases : NMCD
Published: June 15, 2026
VEGFA-Targeted M3-F4 Ionizable Lipid Nanoparticles Improve Diabetic Retinopathy.
Journal: Molecular pharmaceutics
Published: May 06, 2026
MSC-derived small extracellular vesicles attenuate diabetic retinopathy through miR-29a-3p regulated microglia M1-like polarization.
Journal: Experimental eye research
Published: February 26, 2025
Mesenchymal stem cell membrane camouflaged mesoporous polydopamine for Parkinson's disease treatment via alleviating oxidative stress mediated neuroinflammation.
Journal: Biomaterials
Published: January 20, 2025
Artificial mesenchymal stem cell extracellular vesicles enhanced ischemic stroke treatment through targeted remodeling brain microvascular endothelial cells.
Journal: Acta pharmaceutica Sinica. B
Published: January 17, 2025
Inhibition of Cullin3 Neddylation Alleviates Diabetic Retinopathy by Activating Nrf2 Signaling to Combat ROS-Induced Oxidative Stress and Inflammation.
Journal: Inflammation
Published: December 25, 2024
MiR-125a-5p in MSC-derived small extracellular vesicles alleviates Müller cells injury in diabetic retinopathy by modulating mitophagy via PTP1B pathway.
Journal: Cell death discovery
Published: November 18, 2024
MSC-derived exosomal miR-125b-5p suppressed retinal microvascular endothelial cell ferroptosis in diabetic retinopathy.
Journal: Stem cells (Dayton, Ohio)
Published: September 25, 2024
MSC-derived small extracellular vesicles mitigate diabetic retinopathy by stabilizing Nrf2 through miR-143-3p-mediated inhibition of neddylation.
Journal: Free radical biology & medicine
Published: February 28, 2024
Last Updated: 09/26/2026